(6R,11S)-8-(1,6-dimethylpyrazolo[5,4-d]pyrimidin-4-yl)-11-hydroxy-2,8-diazaspiro[5.5]undecan-1-one
C16H22N6O2 — CID 164699612
Data last refreshed: (MolForge compound catalog, from PubChem)
About (6R,11S)-8-(1,6-dimethylpyrazolo[5,4-d]pyrimidin-4-yl)-11-hydroxy-2,8-diazaspiro[5.5]undecan-1-one
(6R,11S)-8-(1,6-dimethylpyrazolo[5,4-d]pyrimidin-4-yl)-11-hydroxy-2,8-diazaspiro[5.5]undecan-1-one (PubChem CID 164699612) has the molecular formula C16H22N6O2 and a molecular weight of 330.39 g/mol. Its IUPAC name is (6R,11S)-8-(1,6-dimethylpyrazolo[5,4-d]pyrimidin-4-yl)-11-hydroxy-2,8-diazaspiro[5.5]undecan-1-one.
Molecular Properties
| Compound Name | (6R,11S)-8-(1,6-dimethylpyrazolo[5,4-d]pyrimidin-4-yl)-11-hydroxy-2,8-diazaspiro[5.5]undecan-1-one |
|---|---|
| PubChem CID | 164699612 |
| Molecular Formula | C16H22N6O2 |
| Molecular Weight | 330.39 g/mol |
| Exact Mass | 330.18 |
| IUPAC Name | (6R,11S)-8-(1,6-dimethylpyrazolo[5,4-d]pyrimidin-4-yl)-11-hydroxy-2,8-diazaspiro[5.5]undecan-1-one |
| SMILES | Cc1nc(N2CC[C@H](O)[C@@]3(CCCNC3=O)C2)c2cnn(C)c2n1 |
| InChI | InChI=1S/C16H22N6O2/c1-10-19-13-11(8-18-21(13)2)14(20-10)22-7-4-12(23)16(9-22)5-3-6-17-15(16)24/h8,12,23H,3-7,9H2,1-2H3,(H,17,24)/t12-,16+/m0/s1 |
| InChIKey | VNZGDNMESVGYMC-BLLLJJGKSA-N |
| XLogP | 0.14 |
| TPSA | 96.17 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 1 |
| Heavy Atoms | 24 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 330.39 |
| LogP ≤ 5 | 0.14 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 164699612 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.